SEC Filing Summary: BioSig Technologies, Inc.
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. (not Streamex Corp.) on September 15, 2014, covering events occurring on September 12, 2014. The filing details the final closing of a private placement transaction under a Securities Purchase Agreement dated August 15, 2014.
Key Financial Metrics and Transaction Details
The filing reports a capital raise event rather than operational financial results. Key metrics for the September 12, 2014 closing include:
- Consideration Received: $390,000
- Common Stock Issued: 156,000 shares
- Warrants Issued: 78,000 five-year warrants
- Warrant Exercise Price: $2.75 per share
Cumulative Transaction Totals (August 15 and September 12 Closings):
- Total Consideration: $953,000 ($563,000 initial + $390,000 final)
- Total Common Stock Issued: 381,200 shares
- Total Warrants Issued: 190,600 warrants
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity positions.
Material Changes
The primary material change is the increase in outstanding equity and potential dilution resulting from the issuance of 156,000 shares and 78,000 warrants to additional accredited investors. This represents the completion of the funding round initiated on August 15, 2014.
Guidance, Risks, and Unusual Items
Regulatory Status: The securities were sold unregistered under Section 4(2) and Regulation D (Rule 506) of the Securities Act of 1933 to accredited investors only.
Registration Rights: Investors entered into a Registration Rights Agreement, granting them rights to request registration of their securities.
Outlook: The filing contains no forward-looking guidance, management commentary on operations, or discussion of risks beyond the standard legal disclaimers regarding the transaction terms.
Investor Verification Checklist
- Verify the total number of outstanding shares post-issuance to assess dilution impact.
- Review the full text of the Securities Purchase Agreement and Registration Rights Agreement (Exhibits 10.1 and 10.3) for specific covenants or restrictions.
- Confirm the company's current cash position and burn rate, as this filing does not disclose liquidity levels.
- Check for any subsequent filings regarding the use of the $953,000 raised.